Search by Drug Name or NDC
NDC 70710-1221-01 CARBIDOPA 25 mg/1 Details
CARBIDOPA 25 mg/1
CARBIDOPA is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is CARBIDOPA.
MedlinePlus Drug Summary
The combination of levodopa and carbidopa is used to treat the symptoms of Parkinson's disease and Parkinson's-like symptoms that may develop after encephalitis (swelling of the brain) or injury to the nervous system caused by carbon monoxide poisoning or manganese poisoning. Parkinson's symptoms, including tremors (shaking), stiffness, and slowness of movement, are caused by a lack of dopamine, a natural substance usually found in the brain. Levodopa is in a class of medications called central nervous system agents. It works by being converted to dopamine in the brain. Carbidopa is in a class of medications called decarboxylase inhibitors. It works by preventing levodopa from being broken down before it reaches the brain. This allows for a lower dose of levodopa, which causes less nausea and vomiting.
Related Packages: 70710-1221-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Levodopa and Carbidopa
Product Information
| NDC | 70710-1221 |
|---|---|
| Product ID | 70710-1221_3abe5c9f-1e44-4fe7-b5d1-70f66f2bcfe1 |
| Associated GPIs | |
| GCN Sequence Number | 043713 |
| GCN Sequence Number Description | carbidopa TABLET 25 MG ORAL |
| HIC3 | C7B |
| HIC3 Description | DECARBOXYLASE INHIBITORS |
| GCN | 50692 |
| HICL Sequence Number | 020613 |
| HICL Sequence Number Description | CARBIDOPA |
| Brand/Generic | Generic |
| Proprietary Name | CARBIDOPA |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | CARBIDOPA |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | CARBIDOPA |
| Labeler Name | Zydus Pharmaceuticals USA Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA209910 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70710-1221-01 (70710122101)
| NDC Package Code | 70710-1221-1 |
|---|---|
| Billing NDC | 70710122101 |
| Package | 100 TABLET in 1 BOTTLE (70710-1221-1) |
| Marketing Start Date | 2018-09-06 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.34628 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | CARBIDOPA 25 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |